gabapentin has been researched along with Pelvic Pain in 22 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Pelvic Pain: Pain in the pelvic region of genital and non-genital origin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was adequately powered, but treatment with gabapentin did not result in significantly lower pain scores in women with chronic pelvic pain, and was associated with higher rates of side-effects than placebo." | 9.34 | Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial. ( Daniels, JP; Doust, AM; Hewitt, CA; Horne, AW; Koscielniak, M; Middleton, LJ; Szubert, W; Vincent, K, 2020) |
| "Chronic pelvic pain in women may be treated sufficiently with Gabapentin." | 9.30 | Gabapentin for the management of chronic pelvic pain in women. ( AbdelHafeez, MA; El-Zeneiny, H; Elnaggar, A; Mokhles, JM; Reda, A, 2019) |
| "To inform feasibility and design of a future randomised controlled trial (RCT) using brain functional MRI (fMRI) to determine the mechanism of action of gabapentin in managing chronic pelvic pain (CPP) in women." | 9.30 | The use of brain functional magnetic resonance imaging to determine the mechanism of action of gabapentin in managing chronic pelvic pain in women: a pilot study. ( Horne, AW; Murnane, J; Murray, SR; Pernet, C; Seretny, M; Whalley, H; Whitaker, L, 2019) |
| " Gabapentin (a GABA analogue) is efficacious and often well tolerated in other chronic pain conditions." | 9.27 | GaPP2, a multicentre randomised controlled trial of the efficacy of gabapentin for the management of chronic pelvic pain in women: study protocol. ( Baranowski, A; Bhattacharya, S; Birch, J; Cheong, Y; Cregg, R; Daniels, J; Hewitt, CA; Horne, AW; Macfarlane, GJ; Middleton, L; Szubert, W; Tracey, I; Vincent, K; Williams, ACC, 2018) |
| " Based on the efficacy of gabapentin in the treatment of chronic pain, we conducted this study to evaluate the efficacy and safety of gabapentin in reducing pain in women with CPP." | 9.22 | Is gabapentin effective and safe in the treatment of chronic pelvic pain in women: a systematic review and meta-analysis. ( He, Y; Ma, W; Zhuang, X, 2022) |
| "The aim of this study was to compare the efficacy and side effects of gabapentin, amitriptyline, and their combination in women with chronic pelvic pain." | 9.11 | Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. ( Ellend, A; Frickey, N; Gleiss, A; Kozek-Langenecker, SA; Kress, HG; Sator-Katzenschlager, SM; Scharbert, G, 2005) |
| "This study was adequately powered, but treatment with gabapentin did not result in significantly lower pain scores in women with chronic pelvic pain, and was associated with higher rates of side-effects than placebo." | 5.34 | Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial. ( Daniels, JP; Doust, AM; Hewitt, CA; Horne, AW; Koscielniak, M; Middleton, LJ; Szubert, W; Vincent, K, 2020) |
| "Chronic pelvic pain in women may be treated sufficiently with Gabapentin." | 5.30 | Gabapentin for the management of chronic pelvic pain in women. ( AbdelHafeez, MA; El-Zeneiny, H; Elnaggar, A; Mokhles, JM; Reda, A, 2019) |
| "To inform feasibility and design of a future randomised controlled trial (RCT) using brain functional MRI (fMRI) to determine the mechanism of action of gabapentin in managing chronic pelvic pain (CPP) in women." | 5.30 | The use of brain functional magnetic resonance imaging to determine the mechanism of action of gabapentin in managing chronic pelvic pain in women: a pilot study. ( Horne, AW; Murnane, J; Murray, SR; Pernet, C; Seretny, M; Whalley, H; Whitaker, L, 2019) |
| " Gabapentin (a GABA analogue) is efficacious and often well tolerated in other chronic pain conditions." | 5.27 | GaPP2, a multicentre randomised controlled trial of the efficacy of gabapentin for the management of chronic pelvic pain in women: study protocol. ( Baranowski, A; Bhattacharya, S; Birch, J; Cheong, Y; Cregg, R; Daniels, J; Hewitt, CA; Horne, AW; Macfarlane, GJ; Middleton, L; Szubert, W; Tracey, I; Vincent, K; Williams, ACC, 2018) |
| " Based on the efficacy of gabapentin in the treatment of chronic pain, we conducted this study to evaluate the efficacy and safety of gabapentin in reducing pain in women with CPP." | 5.22 | Is gabapentin effective and safe in the treatment of chronic pelvic pain in women: a systematic review and meta-analysis. ( He, Y; Ma, W; Zhuang, X, 2022) |
| "The aim of this study was to compare the efficacy and side effects of gabapentin, amitriptyline, and their combination in women with chronic pelvic pain." | 5.11 | Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. ( Ellend, A; Frickey, N; Gleiss, A; Kozek-Langenecker, SA; Kress, HG; Sator-Katzenschlager, SM; Scharbert, G, 2005) |
| "Chronic pelvic pain is a common and debilitating condition; its aetiology is multifactorial, involving social, psychological and biological factors." | 2.50 | Non-surgical interventions for the management of chronic pelvic pain. ( Cheong, YC; Smotra, G; Williams, AC, 2014) |
| "Recent awareness that chronic pain may occur after childbirth has prompted clinicians and researchers to investigate this topic." | 2.49 | Chronic pain after childbirth. ( Bollag, L; Landau, R; Ortner, C, 2013) |
| "The analysis of the case of vulvodynia coexisting with depression." | 1.46 | Vulvodynia and depression - a case study. ( Derewianka-Polak, M; Dziwota, EA; Gerhant, A; Olajossy, M; Perzyńska-Starkiewicz, A, 2017) |
| "Pelvic pain was detected 5 days after antigen instillation and was sustained beyond 30 days, indicating the development of chronic pain." | 1.35 | Experimental autoimmune prostatitis induces chronic pelvic pain. ( Rudick, CN; Schaeffer, AJ; Thumbikat, P, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 12 (54.55) | 24.3611 |
| 2020's | 4 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y | 1 |
| Zhuang, X | 1 |
| Ma, W | 1 |
| Ghaith, S | 1 |
| Quillen, JK | 1 |
| Mead-Harvey, C | 1 |
| Buras, MR | 1 |
| Wasson, MN | 1 |
| AbdelHafeez, MA | 1 |
| Reda, A | 1 |
| Elnaggar, A | 1 |
| El-Zeneiny, H | 1 |
| Mokhles, JM | 1 |
| Horne, AW | 5 |
| Vincent, K | 4 |
| Hewitt, CA | 2 |
| Middleton, LJ | 1 |
| Koscielniak, M | 1 |
| Szubert, W | 2 |
| Doust, AM | 1 |
| Daniels, JP | 1 |
| Cregg, R | 2 |
| Daniels, J | 2 |
| Duffy, JMN | 1 |
| Gerhant, A | 1 |
| Dziwota, EA | 1 |
| Perzyńska-Starkiewicz, A | 1 |
| Derewianka-Polak, M | 1 |
| Olajossy, M | 1 |
| Baranowski, A | 1 |
| Bhattacharya, S | 2 |
| Birch, J | 1 |
| Cheong, Y | 1 |
| Macfarlane, GJ | 1 |
| Middleton, L | 1 |
| Tracey, I | 1 |
| Williams, ACC | 1 |
| Biggs, WS | 1 |
| Carey, ET | 1 |
| McIntyre, JM | 1 |
| Till, SR | 1 |
| As-Sanie, S | 1 |
| Schrepf, A | 1 |
| Seretny, M | 1 |
| Murray, SR | 1 |
| Whitaker, L | 1 |
| Murnane, J | 1 |
| Whalley, H | 1 |
| Pernet, C | 1 |
| Landau, R | 1 |
| Bollag, L | 1 |
| Ortner, C | 1 |
| Cheong, YC | 1 |
| Smotra, G | 1 |
| Williams, AC | 1 |
| Lewis, SC | 1 |
| Wu, O | 1 |
| Jack, SA | 1 |
| Critchley, HO | 1 |
| Porter, MA | 1 |
| Cranley, D | 1 |
| Wilson, JA | 1 |
| Levy, BS | 1 |
| Apgar, BS | 1 |
| Strauss, AC | 1 |
| Dimitrakov, JD | 1 |
| Sator-Katzenschlager, SM | 1 |
| Scharbert, G | 1 |
| Kress, HG | 1 |
| Frickey, N | 1 |
| Ellend, A | 1 |
| Gleiss, A | 1 |
| Kozek-Langenecker, SA | 1 |
| Rudick, CN | 1 |
| Schaeffer, AJ | 1 |
| Thumbikat, P | 1 |
| Solaro, C | 1 |
| Uccelli, MM | 1 |
| Mancardi, GL | 1 |
| Ben-David, B | 1 |
| Friedman, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Musculoskeletal and Pelvic Floor Health in Female Chronic Overlapping Pelvic Pain Conditions (The MSK-PELVIC Study)[NCT05750212] | 208 participants (Anticipated) | Observational | 2023-01-24 | Recruiting | |||
| Oral Gabapentin in Management of Chronic Pelvic Pain in Females: A Randomised Placebo-controlled Study.[NCT02918760] | Phase 3 | 64 participants (Anticipated) | Interventional | 2016-03-31 | Recruiting | ||
| Effects of Muscle Energy Technique Versus Aerobic Exercises on Pain and Disability in Patients With Chronic Pelvic Pain[NCT05429957] | 40 participants (Actual) | Interventional | 2022-01-20 | Completed | |||
| Diagnostic Challenges in IC (and Male CPPS)[NCT00672087] | 1,000 participants (Anticipated) | Observational | 2003-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for gabapentin and Pelvic Pain
| Article | Year |
|---|---|
Is gabapentin effective and safe in the treatment of chronic pelvic pain in women: a systematic review and meta-analysis.
Topics: Amines; Analgesics; Chronic Pain; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyri | 2022 |
Limited evidence guides empiric Tx of female chronic pelvic pain.
Topics: Adult; Amitriptyline; Analgesics; Chronic Pain; Contraceptive Agents, Female; Contraceptives, Oral, | 2018 |
Psychology of Chronic Pelvic Pain: Prevalence, Neurobiological Vulnerabilities, and Treatment.
Topics: Antidepressive Agents, Tricyclic; Anxiety; Catastrophization; Chronic Pain; Cognitive Behavioral The | 2019 |
Chronic pain after childbirth.
Topics: Acute Pain; Adrenergic alpha-Agonists; Adult; Amines; Analgesics; Anesthetics, Dissociative; Cesarea | 2013 |
Non-surgical interventions for the management of chronic pelvic pain.
Topics: Amines; Amitriptyline; Analgesics; Chronic Pain; Clonidine; Contraceptive Agents, Female; Cyclohexan | 2014 |
The complex nature of chronic pelvic pain.
Topics: Adult; Amines; Anti-Anxiety Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, | 2007 |
New treatments for chronic prostatitis/chronic pelvic pain syndrome.
Topics: Amines; Chronic Disease; Cognitive Behavioral Therapy; Cyclohexanecarboxylic Acids; Gabapentin; gamm | 2010 |
7 trials available for gabapentin and Pelvic Pain
| Article | Year |
|---|---|
Gabapentin for the management of chronic pelvic pain in women.
Topics: Adult; Analgesics; Chronic Pain; Double-Blind Method; Female; Gabapentin; Humans; Pelvic Pain | 2019 |
Gabapentin for the management of chronic pelvic pain in women.
Topics: Adult; Analgesics; Chronic Pain; Double-Blind Method; Female; Gabapentin; Humans; Pelvic Pain | 2019 |
Gabapentin for the management of chronic pelvic pain in women.
Topics: Adult; Analgesics; Chronic Pain; Double-Blind Method; Female; Gabapentin; Humans; Pelvic Pain | 2019 |
Gabapentin for the management of chronic pelvic pain in women.
Topics: Adult; Analgesics; Chronic Pain; Double-Blind Method; Female; Gabapentin; Humans; Pelvic Pain | 2019 |
Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Analgesics; Chronic Pain; Double-Blind Method; Female; Gabapentin; Humans; Off-La | 2020 |
Gabapentin not effective for chronic pelvic pain in women.
Topics: Adolescent; Adult; Analgesics; Chronic Disease; Double-Blind Method; Female; Gabapentin; Humans; Mid | 2021 |
GaPP2, a multicentre randomised controlled trial of the efficacy of gabapentin for the management of chronic pelvic pain in women: study protocol.
Topics: Adolescent; Adult; Amines; Analgesics; Chronic Disease; Chronic Pain; Cyclohexanecarboxylic Acids; D | 2018 |
The use of brain functional magnetic resonance imaging to determine the mechanism of action of gabapentin in managing chronic pelvic pain in women: a pilot study.
Topics: Adolescent; Adult; Analgesics; Brain; Brain Mapping; Chronic Pain; Female; Gabapentin; Humans; Magne | 2019 |
Gabapentin for the Management of Chronic Pelvic Pain in Women (GaPP1): A Pilot Randomised Controlled Trial.
Topics: Adolescent; Adult; Amines; Analgesics; Chronic Pain; Cost-Benefit Analysis; Cyclohexanecarboxylic Ac | 2016 |
Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study.
Topics: Adult; Amines; Amitriptyline; Austria; Chronic Disease; Cyclohexanecarboxylic Acids; Drug Combinatio | 2005 |
8 other studies available for gabapentin and Pelvic Pain
| Article | Year |
|---|---|
Impact of timing of preoperative gabapentin administration on postoperative somnolence.
Topics: Adult; Analgesics, Opioid; Female; Gabapentin; Humans; Pelvic Pain; Respiratory Insufficiency; Retro | 2022 |
Is gabapentin effective for women with unexplained chronic pelvic pain?
Topics: Amines; Analgesics; Chronic Pain; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyri | 2017 |
How should we manage women with unexplained chronic pelvic pain in light of uncertainty about the effectiveness of gabapentin?
Topics: Chronic Pain; Female; Gabapentin; Humans; Pelvic Pain; Uncertainty | 2017 |
Vulvodynia and depression - a case study.
Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Depression; Female; Gabapentin; gamma-Aminobutyric | 2017 |
Challenges of fragmented care in long-term management of pelvic pain.
Topics: Acetaminophen; Adult; Amines; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Anxiety Agents; Chr | 2007 |
Experimental autoimmune prostatitis induces chronic pelvic pain.
Topics: Amines; Analgesics; Anesthetics, Local; Animals; Autoimmune Diseases; Chronic Disease; Cyclohexaneca | 2008 |
A patient with multiple sclerosis and Down's syndrome with a rare paroxysmal symptom at onset.
Topics: Acetates; Amines; Brain; Cyclohexanecarboxylic Acids; Down Syndrome; Excitatory Amino Acid Antagonis | 1999 |
Gabapentin therapy for vulvodynia.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Amines; Analgesics; Chronic Disease; Cyclohexanecarboxylic | 1999 |